BNP Paribas Maintains Neutral on Clorox, Lowers Price Target to $95
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
BNP Paribas analyst Kevin Grundy maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $97 to $95.
BNP Paribas analyst Kevin Grundy maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $97 to $95.